Falsified Medicines Directive (FMD) Dispensing Doctors Association Wednesday 18-Oct-17 Jerome Bertin
|
|
- Clare Lawson
- 6 years ago
- Views:
Transcription
1 Falsified Medicines Directive (FMD) Dispensing Doctors Association Wednesday 18-Oct-17 Jerome Bertin
2 Objectives What is FMD all about and when does it need to happen? Who are SecurMed and what is our role in FMD? What is the scope of FMD and who is obliged to comply? What do you need do to prepare for FMD?
3 Falsified Medicines - What is the problem? There is an alarming increase of medicinal products detected in the Union which are falsified in relation to their identity, history or source. These products usually contain substandard or falsified ingredients, or no ingredients, or ingredients (including active substances) in the wrong dosage thus posing an important threat to public health. Directive 2011/62/EU, Para 2 Involving nearly 2500 cases, EU Customs seized 27.4 million doses of falsified medicines at EU borders in an almost seven-fold increase from 2007 MHRA seized 8.6m and discovered fraudsters are infiltrating the NHS drugs supply chain and diverting medicines to street drug dealers and illegal websites May 2014 MHRA seized 6.2m medicine doses/ medical devices worth 15.8m as part of Operation Pangea June 2015 Herceptin, Spiriva Turbohaler and Kaletra WHO estimated in 2014 that 1% of sales in developed countries could be counterfeit. With approx. 2 billion items dispensed per year in the UK, this would equate to 20 million medicine packs if correct. But where is the evidence?
4 Safety features added to medicine packs Introduced to enable wholesale distributors (all WDA holders) and those who supply to patients: to verify the authenticity of the medicinal product, to identify individual packs, to verify whether the outer packaging has been tampered with (Anti-Tamper Device check) Marketing Authorisation Holders (MAHs) obliged to add Safety Features on all Prescription Only Medicines (POMs), except excluded POM medicines and included General Supply List (GSL) medicines Anti-tamper Device Unique identifier Data-Matrix Code Randomised serial number Product #: Batch: A1C2E3G4I5 Expiry: S/N: 12345AZRQF1
5 Some labelled packs are already out there FMD requires Prescription Only Medicines (POMs) to be verified/decommissioned Key labelling feature s shown Product Code (GTIN) Batch Number Expiry Date Unique serial number 2D encoded matrix (for scanner) No anti-tamper proofing on these packs Picture taken at Minal Pharmacy, Twickenham, 15-Sep-17
6 Point of Dispense Verification Required by Delegated Regulation Commissioning Verification Decommissioning
7 SecurMed UK - NMVO Service A not for profit legal entity to establish and manage the verification system. A joint venture funded by pharmaceutical industry via industry associations Scope governed by Delegated Regulation of Falsified Medicines Directive UK Blueprint Service Provider is Arvato s GmbH Supervised by National Competent Authority (DH/MHRA)
8 Wholesaler Interface Manufacturer Interface Interface NMVO Scope of Responsibility Manufacturer European Medicines Verification (EMVS) Paralell Parallel Distributor Interface Wholesaler/ Distributor Interface UK MVS UK Medicines Verification (SecurMed MVS) Interface Interface Build and test SecurMed MVS Enable IT providers to create connections On-board wholesale and dispensing users Develop UK NMVO Service Reporting exceptions & compliance to NCAs. Maintain data integrity and security for all users Pharmacy Hospital Other Article 23 Locations Community Pharmacy Hospital Pharmacy Other Dispensing 8
9 UK FMD Implementation Overview NMVO IT Solution Providers Community Pharmacy UK Medicines Verification (UK MVS) Wholesaler /Distributor to Connections End User to IT Provider Hospital Pharmacy GP Practice /Health Centre End User Registration/ Legitimacy Check SecurMed/Arvato provide IT Provider Solution Developers Kit and User Onboarding IT Solution Providers develop end user solutions encompassing IT system changes, interface to UK MVS, scanners, upgraded IT infrastructure and working practices changes End Users Community Pharmacy Users Wholesaler Users/ Article 23 Hospital Pharmacy Users GP Practice /Health Centre Users Registration Body e.g GPhC, CQC, GMC, PSNI End users verify/ decommission/ dispense medicines in supply chain through to dispense to patients 9
10 Costs are incurred by all stakeholders Verification system (Hub & national systems) Installation for pack coding Installations for pack verification Pharmaceutical Manufacturer European Hub Parallel Distributor Pharmacy Wholesaler Manufacturers and Marketing Authorisation Holders Manufacturers and Marketing Authorisation Holders Dispensing & Verification Entities e.g. Pharmacies, Hospitals and Wholesalers Each stakeholder pays for costs of own installations. Manufacturers pay for cost of the verification system. SecurMed is funded only for UK system set-up, no-one else.
11 FMD and Brexit FMD legislation passed into UK law in 2013 (part of Human Medicines Act). Delegated Regulation approved by UK government in DH MHRA position April Until exit negotiations are concluded the UK remains a full member of the EU and all the rights and obligations of EU membership remain in force. During this period, the government will continue to negotiate, implement and apply EU legislation, including the Safety Features policy under the Falsified Medicines Directive. The outcome of the exit negotiations will help determine what arrangements will apply once the UK has left the EU, however the government remains committed to providing a regulatory environment which protects health and improves lives. SecurMed UK has been instructed to continue as full member of Europe-wide FMD implementation. SecurMed has sought guidance from Dept of Health/MHRA since the General Election and the direction remains the same. Arvato s appointed on 18-Jul-2017 as UK Blueprint Service Provider.
12 FMD is a Regulatory requirement Objective: Protection of patients from falsified medicines in the legal distribution chain Delivery: Pan-European system to verify the authenticity of medicinal products July 2011 Jan 2013 Publication of FMD except FMD Safety Features implemented Oct 2015 Delegated Regulation approved by UK Ministers 9 February 2016 Publication of Delegated Regulation 36 Mon (2015+3) Complete Implementation Non-compliance puts supply and sales at risk FMD Go-Live - 09 February 2019
13 FMD Implementation Scope In FMD Implementation Scope England, Scotland, Wales, Northern Ireland, Channel Islands, Isle of Man All persons authorized to dispense medicines to the public All pharmacies and healthcare institutions supplying medicines to the public All wholesalers holding Wholesaler Dealer Authorisations Article 3 healthcare institution means a hospital, in- or out-patient clinic or a health centre. Dept of Health have confirmed all GP practices and surgeries are considered healthcare institutions (July 2016). Article 23 persons authorized to supply medicines to the public who do not operate within a healthcare institution or a pharmacy (managed by wholesaler) Dentists, vets, opticians, paramedics, universities/ higher education, prisons, hospices, nursing/ care homes (subject to confirmation by DH/MHRA) Out of FMD implementation scope British Overseas Territories e.g. Gibraltar and Crown Dependencies e.g Bermuda, Falkland Islands, St Helena (subject to MHRA confirmation) All other healthcare organisations e.g Phone/Advice Lines
14 Size of UK User Community Channel Islands Isle of Man England, Scotland, Wales, Northern Ireland, Channel Islands, Isle of Man 15,000 Community Pharmacies 260 Acute NHS Hospital Trusts 190 Private Hospitals 1,200 Dispensing Doctors 9,800 GP Practices & Surgeries 2,160 Wholesaler/ Dealer Authorisations 200,000+ End Users to be trained 17,000+ Article 23 locations 18,000 Other Locations (Care Homes, etc) Market Authorisation Holders (MHRA & EMA) Ministry of Defence 60+ IT Solution Providers
15 What happens next? FMD is a regulatory change Dept of Health/MHRA to issue a Public Consultation later this year. Legislation for the Delegated Regulation issued in Department of Health to initiate GP/Health Centre change programme NHS Digital are aware for NHS England and are setting up a team to support GPs/Health Centres. NHS Services in devolved countries not yet engaged. NHS Digital to advise on when GP IT providers will be engaged. Changes will be needed to IT systems IT system change to enable medicines verification. Scanners to scan medicine packs. Changes to ways of working. Raise awareness this is coming so impact can be assessed and change planned.
16 Where to get more information? SecurMed UK: Community Pharmacy FMD: To register for the monthly MHRA FMD Safety Features newsletter please with your name, organisation and your title.
17 Questions?
Falsified Medicines Directive (FMD) EMIG Quarterly Meeting Monday 06-Nov-17
Falsified Medicines Directive (FMD) EMIG Quarterly Meeting Monday 06-Nov-17 Objectives What is FMD all about and when does it need to happen? Who are SecurMed UK and what is our role in FMD? What is the
More informationDe EMVO en de NMVO: Hoe staat Europa ervoor?
Bogin symposium 2017 Wat brengt ons de implementatie van de FMD? De EMVO en de NMVO: Hoe staat Europa ervoor? Johan Verhaeghe National Policy Liaison Utrecht 23 November 2017 agenda About Medicines for
More informationFalsified Medicines Directive - Safety Features Update
Falsified Medicines Directive - Safety Features Update Catherine Neary GMP Conference 12 th November 2014 Agenda Background Delegated Act(s) Proposals Under Consideration White List & Black List Next Steps
More informationThe fighting in Spain against counterfiting: the Directive and the Delegated Act
The fighting in Spain against counterfiting: the Directive and the Delegated Act Belén Escribano Head of the Pharmaceutical Inspection and Enforcement Department 1 Overview Background Directive implementation
More informationCounterfeit Medicinal Products. FINLAND Roschier, Attorneys Ltd.
Counterfeit Medicinal Products FINLAND Roschier, Attorneys Ltd. CONTACT INFORMATION Mikael Segercrantz Robert Hagelstam Roschier, Attorneys Ltd. Keskuskatu 7 A 00100 Helsinki, Finland 358.20.506.6000 mikael.segercrantz@roschier.com
More informationGuidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business
Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business to Facilitate Compliance with Regulations 5(1)(g), 6, 8 and 11 of the Regulation of Retail Pharmacy Businesses
More informationProf. Stefania Negri Jean Monnet Chair in European Health, Environmental and Food Safety Law
Prof. Stefania Negri Jean Monnet Chair in European Health, Environmental and Food Safety Law SSFFC drugs are medical products that: do not contain any specific active substances, irrespective of the indication
More informationORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies
ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies ISSUING BODY: The Ministry of Health published in: the Official
More informationResponse to Scottish Government A Consultation on Electronic Cigarettes and Strengthening Tobacco Control in Scotland December 2014
Responseto ScottishGovernment AConsultationonElectronicCigarettesand StrengtheningTobaccoControlinScotland December2014 Contact Janice Oman Scotland Representation Manager National Pharmacy Association
More informationRef: E 007. PGEU Response. Consultation on measures for improving the recognition of medical prescriptions issued in another Member State
Ref:11.11.24E 007 PGEU Response Consultation on measures for improving the recognition of medical prescriptions issued in another Member State PGEU The Pharmaceutical Group of the European Union (PGEU)
More informationDIRECTIVE 2011/62/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
L 174/74 Official Journal of the European Union 1.7.2011 DIRECTIVE 2011/62/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to
More informationPharmaceutical System in the UK
Pharmaceutical System in the UK David Kullman Medicines, i Pharmacy and Industry Group Department of Health PPRI Conference, Vienna 30 September 2011 Disclaimer Conflict of interest: Nothing to disclose
More informationChanging practice to support service delivery
Nurse and Midwife Medicinal Product Prescribing Toolkit Authorised Medicinal Products, Off-label Prescription and Exempt Medicinal Products Toolkit Changing practice to support service delivery Introduction
More informationAct on Narcotic Drugs and Psychotropic Substances and Precursors thereof
Issuer: Riigikogu Type: act In force from: 13.05.2016 In force until: 22.11.2018 Translation published: 06.05.2016 Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof Amended by the
More informationMEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH
11 MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH Background The rules in this section are designed to ensure that advertisements that include health claims (please see Section 13 for health claims
More informationMHRA Anti-counterfeiting Strategy and Supply Chain Guidance
Safeguarding public health MHRA Anti-counterfeiting Strategy and Supply Chain Guidance PQG Annual Meeting for QPs 24 Mar 2010 Nimo Ahmed Head of Intelligence Medicines and Healthcare products Regulatory
More informationFRAMEWORK OVERVIEW. Page 1 of 7
FRAMEWORK OVERVIEW HealthTrust Europe s Interpretation and Translation Services framework agreement offers a simple, compliant route to market for the procurement of quality Interpretation and Translation
More informationPrescription only medicines (POMs)
Prescription only medicines (POMs) 2017 Learning objectives Explain the legal framework with which registered health care professionals can administer prescription only medicines Define the role and limitations
More informationHealth Authority Abu Dhabi. Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number:
Health Authority Abu Dhabi Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number: PPR/DMP/DR/P0001 Version 0.9 Approval Date: August 2007 Effective Date: August 2007 Last
More information40 Use and Supply of Drugs or Medicines in Optometric Practice
40 Use and Supply of Drugs or Medicines in Optometric Practice Guideline 40.01 The optometrist has a duty to take due care in the use of drugs in optometric practice and to only supply drugs when it is
More informationQuality, Safety and Sourcing in Unlicensed Medicines
Quality, Safety and Sourcing in Unlicensed Medicines with Andrew Trouton Managing Director, UL Medicines Agenda Welcome What is an unlicensed medicine? When should you consider using an unlicensed medicine?
More informationSTANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE
STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE Laws regulating the sale of tobacco products across the UK are changing. This guidance outlines how retailers must comply with the new regulations.
More informationCase scenarios: Patient Group Directions
Putting NICE guidance into practice Case scenarios: Patient Group Directions Implementing the NICE guidance on Patient Group Directions (MPG2) Published: March 2014 [updated March 2017] These case scenarios
More informationSTANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE
This guidance document contains Assured Advice under the ACS Primary Authority Scheme. For more details visit www.acs.org.uk/assured-advice STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE Laws regulating
More informationPolicy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group
BEFORE USING THIS POLICY ALWAYS ENSURE YOU ARE USING THE MOST UP TO DATE VERSION Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical
More informationFrequently asked questions
13 February 2017 EMA/527628/2011 Rev. 1 Directorate This document provides answers to the most frequently asked questions received by the European Medicines Agency (EMA).If the answer to your question
More informationPresentation to Parliamentary Portfolio Committee on Health
Presentation to Parliamentary Portfolio Committee on Health Bill 6 of 2014 Medicines and Related Substances Amendment Bill Presented by: Anele Vutha South African Medical Device Industry Association 29
More informationLegal Framework: Counterfeit Medicines.
Legal Framework: Counterfeit Medicines. AIFA and the actions against drugs counterfeiting Marcello Chiavoni Zagreb, November 2014 Public Declaration of transparency/interests* The view and opinions expressed
More informationResponse to. GPhC Consultation. Guidance to ensure a safe and effective pharmacy team.
Response to GPhC Consultation on Guidance to ensure a safe and effective pharmacy team. Contact Helga Mangion National Pharmacy Association Mallinson House 38-42 St Peter s Street St Albans Herts AL1 3NP
More informationGuidelines for Product Recall or Withdrawal
REPUBLIC OF KENYA PHARMACY AND POISONS BOARD Guidelines for Product Recall or Withdrawal Edition 1 Date of release for publication June 2006 Date of implementation June 2006 This document has been prepared
More informationCOPYRIGHTED MATERIAL. Introduction
1 Introduction Pharmacology is the science of drugs and their effects on biological systems. A drug can be defined as a chemical that can cause a change in a biological system; the important biological
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
SOP details SOP title: SOP number: SOP category: Version number: 03 Version date: 19 December 2016 Effective date: 19 January 2017 Revision due date: 19 January 2020 NEWCASTLE CLINICAL TRIALS UNIT STANDARD
More informationHealth (Tobacco, Nicotine etc. and Care)(Scotland) Bill. Japan Tobacco International (JTI)
Health (Tobacco, Nicotine etc. and Care)(Scotland) Bill Organisation name Japan Tobacco International (JTI) Japan Tobacco International (JTI) is part of the Japan Tobacco group (JT Group) of companies,
More informationGuide to Interchangeable Medicines
Guide to Interchangeable Medicines AUT-G0115-6 01 JUNE 2018 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS 1 BACKGROUND 3 1.1
More informationMarket surveillance of medical devices
Market surveillance of medical devices A joint action on market surveillance of medical devices to reinforce public health protection Information for healthcare professionals Introduction The European
More informationIssue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES
Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES CONTENTS
More informationNovo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology )
Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology ) Table of contents Preamble... 0 1. General Summary... 1 2. Terminology and Definitions... 2 3. Change log... 8 Preamble Novo
More informationWHAT DO MANUFACTURERS AND IMPORTERS HAVE TO DO TO PREPARE FOR EU MEMBERSHIP?
WHAT DO MANUFACTURERS AND IMPORTERS HAVE TO DO TO PREPARE FOR EU MEMBERSHIP? pharmaceutical regulatory affairs consulting and education www.rapharm.eu Vesna Koblar, MD. PhD. EU28: Science, Medicines, Health
More informationThe Prime Minister s Challenge on Dementia Lorraine Jackson Deputy Director: Dementia Policy Department of Health 12 April 2016
The Prime Minister s Challenge on Dementia 2020 1 Lorraine Jackson Deputy Director: Dementia Policy Department of Health 12 April 2016 Costs and impact of dementia Estimated 676,000 people in England with
More informationLOGO. Falsification of Medicines. Drug Chemistry and Technology Basics, Cleaner Production and Mega-Trends in Pharmaceutical Industry
LOGO Drug Chemistry and Technology Basics, Cleaner Production and Mega-Trends in Pharmaceutical Industry Falsification of Medicines Dr. As. Prof. Anastasiya Sladkova Dr. Sci. Prof. Natalya Loginova 1 Questions
More informationDIRECT ACCESS - Guidance to BSDHT Members
DIRECT CCESS - Guidance to BSDHT Members Direct ccess came into effect from 1 May 2013. But what does it mean for dental hygienists and dental therapists? The GDC have published guidance notes on the subject
More informationINGREDIENT DECLARATION OF COMPOUND FEEDINGSTUFFS BY PERCENTAGE WEIGHT OF INCLUSION ( PERCENTAGE INGREDIENT DECLARATION )
INGREDIENT DECLARATION OF COMPOUND FEEDINGSTUFFS BY PERCENTAGE WEIGHT OF INCLUSION ( PERCENTAGE INGREDIENT DECLARATION ) GUIDANCE ON NEW LABELLING REQUIREMENTS This document is an introductory guide to
More informationNHS Procurement eenablement. Programme
Programme Rachel Hodson-Gibbons Head of eprocurement NHS Purchasing and Supply Agency Agenda The English NHS What is procurement eenablement? Current situation in the NHS? What is the NHS doing? Implementation
More informationPATIENT GROUP DIRECTIONS POLICY
PATIENT GROUP DIRECTIONS POLICY To be read in conjunction with the Medicines Policy and the Controlled Drugs Policy Version: 5 Ratified by: Senior Managers Operations Group Date ratified: August 2015 October
More informationTemplate Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices
Name of Dental Practice : Objectives To ensure implementation of the regulations and guidance on safe and secure handling of midazolam and other controlled drugs (CDs) Scope To cover all aspects of obtaining
More informationAllergy Therapeutics Ltd. Comments on:
Allergy Therapeutics Ltd. Comments on: Delegated act on the detailed rules for a unique identifier for medicinal products for human use, and its verification Concept paper submitted for public consultation
More informationFeidhmeannacht na Seirbhíse Sláinte
Feidhmeannacht na Seirbhíse Sláinte Health Service Executive TITLE FORENAME SURNAME ADDRESS 1 ADDRESS 2 ADDRESS 3 COUNTY Feidhmeannacht na Seirbhíse Sláinte Seirbhís Aisíoca Príomhchúraim Bealach amach
More informationTHE MEDICRIME CONVENTION
Council of Europe THE MEDICRIME CONVENTION Fighting the falsification of medical products and similar crimes The Medicrime Convention in a few words Crime linked to the manufacture, distribution and sale
More informationMedication errors. Impact of medication error guidance and regulation on drug-device combination products. June 2017 Dan Wozinski
Medication errors Impact of medication error guidance and regulation on drug-device combination products June 2017 Dan Wozinski Agenda Understand the management of medication errors within global requirements
More informationTHE MEDICRIME CONVENTION
Council of Europe THE MEDICRIME CONVENTION Fighting the falsification of medical products and similar crimes The MEDICRIME Convention in a few words Crime linked to the manufacture, distribution and sale
More informationHow is the introduction of a new medicine regulated in the UK?
Information provided to Duchenne muscular dystrophy patient organisations regarding Raxone (idebenone) and the Early Access to Medicines Scheme in the UK (EAMS 46555/0001) A medicine called Raxone, which
More informationThe Nutrition (Amendment) (EU Exit) Regulations 2018
The Nutrition (Amendment) (EU Exit) Regulations 2018 A public consultation Contents Introduction... 3 Why we are consulting... 4 Nutrition and Health Claims... 6 Proposals... 6 Vitamins, minerals, and
More informationGuideline scope Smoking cessation interventions and services
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Topic NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Smoking cessation interventions and services This guideline
More informationpí=^åçêéïûë=eçìëé= oéöéåí=oç~ç= bçáåäìêöü=ben=pad= = = IMMEDIATE MESSAGE TO:
abcdefghijklm eé~äíüaéé~êíãéåí pí^åçêéïûëeçìëé oéöéåíoç~ç bçáåäìêöübenpad IMMEDIATE MESSAGE TO: qéäééüçåéwmnpnjoqqjorou c~ñwmnpnjoqqoptr ÉJã~áäWáêÉåÉKÑçëíÉê]ëÅçíä~åÇKÖëáKÖçîKìâ 1. Specialists in Pharmaceutical
More informationReview of Medicines Act 1968: informal consultation on issues relating to the PLR regime and homeopathy
Review of Medicines Act 1968: informal consultation on issues relating to the PLR regime and homeopathy Introduction 1. The consolidation and review of the UK medicines legislation (including the Medicines
More informationYour guide to private dentistry. Questions to ask
Your guide to private dentistry Questions to ask When you are choosing private treatment it pays to shop around and to ask the right questions. Unlike National Health Service (NHS) care, where there are
More informationAustralian Sonographer Accreditation Registry (ASAR) Policy & Procedure 9 - Annual Reporting Requirements for Accredited Sonography Courses
Sonography 1. Preamble ASAR s objective is to promote high standards of medical sonography in Australia which includes setting uniform, minimum standards of sonographer education by assessing and accrediting
More informationControlled Drugs Accountable Officers Network Scotland Executive Group. Gabapentin and Pregabalin - Frequently Asked Questions
Gabapentin and Pregabalin - Frequently Asked Questions Gabapentin and pregabalin will become Schedule 3 Controlled Drugs in April 2019 NHS Contractor Services Prescribers are legally permitted to be in
More informationFrance: Millions of medicines seized in largest INTERPOL operation against illicit online pharmacies
LYON, France, September 25 (Infosplusgabon) - In the largest action of its kind, INTERPOL s Operation Pangea X, targeting the illicit online sale of medicines and medical devices, has resulted in some
More informationTHE RESPONSIBLE PHARMACIST REGULATIONS
THE RESPONSIBLE PHARMACIST REGULATIONS A SUMMARY OF THE RESPONSES TO PUBLIC CONSULTATION ON PROPOSALS FOR THE CONTENT OF THE REGULATIONS DH INFORMATION READER BOX Policy HR / Workforce Management Planning
More informationCOMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES
COMPETENT AUTHORITY (UK) 10 EC MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES (CUSTOM MADE DEVICES) Updated March 2008 CONTENTS PAGE Introduction 3 Definition of dental
More informationREPUBLIC OF KENYA MINISTRY OF HEALTH PHARMACY AND POISONS BOARD DRAFT GUIDELINE FOR IMPORTATION OF ORPHAN MEDICINAL SUBSTANCES IN KENYA
PPB/REG/TRA/GUD/003 REPUBLIC OF KENYA MINISTRY OF HEALTH PHARMACY AND POISONS BOARD DRAFT GUIDELINE FOR IMPORTATION OF ORPHAN MEDICINAL SUBSTANCES IN KENYA September 2015, Version 1 P.O. BOX 27663, LENANA
More informationfor adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services
The supply of Champix (Varenicline) Tablets 500mcg and 1mg by registered community pharmacists for smoking cessation / management of nicotine withdrawal for adults engaged with the Family Wellbeing Service
More informationDIRECT ACCESS Guidance to BSDHT Members
DIRECT CCESS Guidance to BSDHT Members Direct ccess comes into effect from 1 May 2013. But what does it mean for dental hygienists and dental therapists? The GDC have published guidance notes on the subject
More informationInformation provided to Duchenne muscular dystrophy patient organisations regarding Raxone
Information provided to Duchenne muscular dystrophy patient organisations regarding Raxone (idebenone) and the Early Access to Medicines Scheme in the UK (EAMS 46555/0001) April 26 th 2018 Raxone tablets
More informationROLE SPECIFICATION FOR MACMILLAN GPs
ROLE SPECIFICATION FOR MACMILLAN GPs November 2010 History of Macmillan GPs Macmillan Cancer Support has funded GP positions from the early 1990 s, following the success of our investment in supporting
More informationBritish American Tobacco Snus Marketing Standards
British American Tobacco Snus Marketing Standards British American Tobacco p.l.c. believes there is sufficient scientific evidence to support a less restrictive regime for the advertising and promotion
More informationPutting Prevention First
Putting Prevention First BDA Manifesto 2017 About Us The British Dental Association is the voice of dentists and dental students in the UK. Dentists are critical to the health of the nation and we want
More informationCOMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS
COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS 2016-2017 Introduction This summary provides an overview of the activities carried out by
More informationPrescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study
Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study Presented By: Scott McKibbin Special Advocate For Prescription Drugs State Of Illinois
More informationExplanatory Memorandum to the Food Labelling (Declaration of Allergens) (Wales) Regulations 2008
Explanatory Memorandum to the Food Labelling (Declaration of Allergens) (Wales) Regulations 2008 This Explanatory Memorandum has been prepared by the Food Standards Agency Wales and is laid before the
More informationNational Drug and Alcohol Treatment Waiting Times Report
Publication Report National Drug and Alcohol Treatment Waiting Times Report October December 2016 Publication Date 28 March 2017 A National Statistics Publication for Scotland Contents Introduction...
More informationCNHC Guidance on The Cancer Act (Please note this does not constitute legal advice)
CNHC Guidance on The Cancer Act 1939 (Please note this does not constitute legal advice) 1. Introduction 1.1. In November 2012 CNHC produced Advertising Guidance to support CNHC registered practitioners
More informationCouncil of Europe The Medicrime Convention. Combating counterfeiting of medical products and similar crimes
Council of Europe The Medicrime Convention Combating counterfeiting of medical products and similar crimes Counterfeiting of medical products and similar crimes involving threats to public health are a
More informationParallel trade: are industry concerns real or imagined?
Parallel trade: are industry concerns real or imagined? Steve Chaplin MSc, MRPharmS The parallel trade in medicines is claimed to save money for the NHS, but results in lost profits for the pharmaceutical
More informationThe Prime Minister s Challenge on Dementia. Lorraine Jackson Deputy Director: Domestic Dementia Policy Department of Health
The Prime Minister s Challenge on Dementia Lorraine Jackson Deputy Director: Domestic Dementia Policy Department of Health 1 Costs and impact of dementia Estimated 676,000 people in England with dementia,
More informationGuideline on the Regulation of Therapeutic Products in New Zealand
Guideline on the Regulation of Therapeutic Products in New Zealand Part 10: Requirements for information for prescribers and consumers Edition 7.0 January 2016 Section 1: Legislation Section summary This
More informationAGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)
AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred
More informationPATIENT GROUP DIRECTION PROCEDURE
PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen
More information1. Introduction. 2. Role of PSI as Pharmacy Regulator
1. Introduction 1.1. I would like to begin by thanking the Committee for inviting the Pharmaceutical Society of Ireland here today to assist in the Committee s on-going scrutiny of the Cannabis for Medicinal
More informationCouncil of Europe The Medicrime Convention
Council of Europe The Medicrime Convention Combating counterfeiting of medical products and similar crimes What is a counterfeit medical product? It is a product with a deliberately false representation
More informationProposed Radiation Safety Regulations: Submission form
Proposed Radiation Safety Regulations: Submission form Making a submission This form is designed to assist submitters responding to the discussion points in Proposed Radiation Safety Regulations: A consultation
More informationWELSH GOVERNMENT RESPONSE TO RECOMMENDATIONS FROM THE HEALTH & SOCIAL CARE COMMITTEE: INQUIRY INTO NEW PSYCHOACTIVE SUBSTANCES
WELSH GOVERNMENT RESPONSE TO RECOMMENDATIONS FROM THE HEALTH & SOCIAL CARE COMMITTEE: INQUIRY INTO NEW PSYCHOACTIVE SUBSTANCES Recommendation 1 The Committee recommends that the Minister for Health and
More informationRecommendations 2. Council is asked to note and discuss the findings of the research and how we intend to use it.
COUNCIL Survey of contact lens wearers: research findings Meeting: 10 February 2016 Lead responsibility: Alistair Bridge (Director of Strategy) Status: for noting Project manager/paper author: Marie Bunby
More informationPutting NICE guidance into practice. Resource impact report: Hearing loss in adults: assessment and management (NG98)
Putting NICE guidance into practice Resource impact report: Hearing loss in adults: assessment and management (NG98) Published: June 2018 Summary This report focuses on the recommendation from NICE s guideline
More informationChief Dental Officer England: Advice on commercial practice of online registered dental practitioners selling patient group directions for NHS
Chief Dental Officer England: Advice on commercial practice of online registered dental practitioners selling patient group directions for NHS England commissioned services. Chief Dental Officer England:
More informationH 7816 S T A T E O F R H O D E I S L A N D
LC00 01 -- H 1 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO BUSINESSES AND PROFESSIONS - PHARMACIES Introduced By: Representatives Serpa, Canario,
More informationThe Home Office Proposals to schedule pregabalin and gabapentin under the Misuse of Drugs Regulations 2001 January 2018
The Home Office Proposals to schedule pregabalin and gabapentin under the Misuse of Drugs Regulations 2001 January 2018 Prepared by: Adam Osprey Policy & Development Pharmacist adam.osprey@cps.scot Who
More informationGuidance for optometrist prescribers
Guidance for optometrist prescribers Contents Introduction Legislation and terminology Standards for optometrist prescribers Specialist areas of practice Section 1 - Guidance for prescribing practice P1.
More informationPROMOTING HUMAN ORGAN DONATION AND TRANSPLANTATION IN NORTHERN IRELAND. Consultation Proposals & Response Questionnaire
PROMOTING HUMAN ORGAN DONATION AND TRANSPLANTATION IN NORTHERN IRELAND Consultation Proposals & Response Questionnaire 11 December 2017 12 March 2018 Consultation Proposals Policy Objectives and Key Commitments
More informationJOB DESCRIPTION. ImROC Business Manager (Mental Health Network) and Senior. Policy Manager (NHS Clinical Commissioners)
JOB DESCRIPTION Job Title: Location: Salary: Reports To: Accountable To: Team Administrator London 21,630 (plus London weighting) ImROC Business Manager (Mental Health Network) ImROC Business Manager (Mental
More informationEvaluation of the Health and Social Care Professionals Programme Interim report. Prostate Cancer UK
Evaluation of the Health and Social Care Professionals Programme Interim report Prostate Cancer UK July 2014 Contents Executive summary... 2 Summary of the research... 2 Main findings... 2 Lessons learned...
More informationPUBLIC CONSULTATION DOCUMENT
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Directorate C Public Health and Risk Assessment POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC PUBLIC CONSULTATION DOCUMENT
More informationPneumococcal polysaccharide vaccine uptake in England, , prior to the introduction of a vaccination programme for older adults
Journal of Public Health Advance Access published July 7, 2006 Journal of Public Health pp. 1 of 6 doi:10.1093/pubmed/fdl017 Pneumococcal polysaccharide vaccine uptake in England, 1989 2003, prior to the
More informationNational Drug and Alcohol Treatment Waiting Times
National Drug and Alcohol Treatment Waiting Times 1 October 31 December 2017 Publication date 27 March 2018 A National Statistics publication for Scotland This is a National Statistics Publication National
More informationTowards a Smokefree Generation: A Tobacco Control Plan for England. Tim Baxter, Department of Health, England
Towards a Smokefree Generation: A Tobacco Control Plan for England 1 Tim Baxter, Department of Health, England Smoking rates are falling fast... 25 Adult Smoking prevalence in England (daily and non daily)
More informationA guide to essential gluten-free foods available from the pharmacy
A guide to essential gluten-free foods available from the pharmacy This information guide has been produced by For further information: This resource has been reviewed by the British Dietetic Association.
More informationService Specification & Contract Intermediate Stop Smoking Service & Voucher fulfilment - Pharmacy Newcastle
Service Specification & Contract Intermediate Stop Smoking Service & Voucher fulfilment - Pharmacy Newcastle Contents 1. Agreement period 2. Scope 3. Targets 4. Service outline 5. Support for clients using
More informationThe Spreading Plague of Counterfeiting
The Spreading Plague of Counterfeiting Harvey Bale Director General International Federation of Pharmaceutical Manufacturers Associations (IFPMA) PSF Assembly Stockholm 25 October 2003 Rising Tide of a
More informationIndustry s Perspective on the Status of Medical Device Regulations. FUNDISA Workshop 09 & 10 Oct Anele Vutha SAMED Regulatory Committee
Industry s Perspective on the Status of Medical Device Regulations FUNDISA Workshop 09 & 10 Oct 2014 Anele Vutha SAMED Regulatory Committee Today s Topics: 1. Medical Device Definition - Differences 2.
More information